Log in | Join Free | china | japan | germany

BJE6-106 (B106)

Request For Quotation
BJE6-106 (B106) Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:BJE6-106；B106
CAS:1564249-38-2
Purity:98.00% Package:100 mg；500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Products Intro: Product Name:BJE6-106
CAS:1564249-38-2
Purity:99% Package:10kg 25kg 200 kilograms per barrel Remarks:good
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:BJE6-106
CAS:1564249-38-2
Purity:99% Package:$350.9/5mg;$590.9/10mg;$1800.9/50mg;$2800.9/100mg;Bulk package Remarks:99%
Company Name: Sichuan Wei Keqi Biological Technology Co., Ltd.  
Tel: 028-81700200 18116577057
Email: 3003855609@qq.com
Products Intro: Product Name:B106
CAS:1564249-38-2
Purity:HPLC≥98% Package:20mg/10
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:B106
CAS:1564249-38-2
Purity:98% Package:5mg;25mg
BJE6-106 (B106) Basic information
Product Name:BJE6-106 (B106)
Synonyms:BJE6-106 (B106);B106;BJE6106,BJE-6-106,BJE6 106;2H-1-Benzopyran-8-carboxaldehyde, 6-[2-(9H-carbazol-9-yl)ethyl]-2,2-dimethyl-
CAS:1564249-38-2
MF:C26H23NO2
MW:381.47
EINECS:
Product Categories:
Mol File:1564249-38-2.mol
BJE6-106 (B106) Structure
BJE6-106 (B106) Chemical Properties
Boiling point 548.1±50.0 °C(Predicted)
density 1.16±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO:50.0(Max Conc. mg/mL);131.07(Max Conc. mM)
Safety Information
MSDS Information
BJE6-106 (B106) Usage And Synthesis
Biological ActivityBJE6-106 (B106) is a potent and selective PKCδ inhibitor with IC50 value of 0.05 μM, BJE6-106 (B106) targets PKCδ 1000-fold more selective than the PKC isoenzyme PKCα (IC50=50 μM) . BJE6-106 (B106) induces apoptosis in caspase-dependent cells. BJE6-106 (B106) has tumor-specific effects.
in vitro

BJE6-106 (B106) (0.2 μM, 0.5 μM; 24-72 hours) suppresses cell survival in melanoma cell lines with NRAS mutations. BJE6-106 (B106) (0.2 μM, 0.5 μM; 6- 24 hours) triggers caspase-dependent apoptosis, increases the activity of caspase 3/7, the effect of B106 is greater than rottlerin (10-fold) in SBcl2 cells. BJE6-106 (B106) (0.5 μM; 2-10 hours) activates the MKK4-JNK-H2AX Pathway by inducing MKK4, JNK and H2AX activation at different times in SBcl2 cells.

Cell Viability Assay

Cell Line: Melanoma cell lines with NRAS mutations: SBcl2, FM6, SKMEL2, WM1366, WM1361A, and WM852 cells
Concentration: 0.2 μM, 0.5 μM
Incubation Time: 24 hours, 48 hours, or 72 hours
Result: Inhibited cell survival in melanoma cell lines.

Apoptosis Analysis

< td class="col2"> SBcl2 cells
Cell Line:
Concentration: 0.2 μM, 0.5 μM
Incubation Time: 6 hours, 12 hours, or 24 hours
Result: Induced caspase 3/7 activation.

Western Blot Analysis

< /tr> Result:
Cell Line : SBcl2 cells
Concentration: 0.2 μM , 0.5 μM
Incubation Time: 2 hours, 5 hours, 10 hours
Increased phosphorylation of MKK4, JNK and H2AX.
target

PKCδ

0.05 μM (IC 50 )

PKCα

50 μM (IC 50 )

BJE6-106 (B106) Preparation Products And Raw materials
Tag:BJE6-106 (B106)(1564249-38-2) Related Product Information